Abstract submissions must be received by 30 March 2025 for consideration.
Abstract SubmissionTimeline
-
Submission Deadline
30 March 2025
Last day to submit abstracts, submission site closes at 23:59 CET
-
Final PDF Poster Submission Date
08 August 2025
Deadline for final printable PDF submission
Each abstract must include the following information to be considered:
- Presentation Title
- Presenter's Name And Contact Details
-
Presenter's Biography
(Approx. 100 words) -
Additional Speakers
(If applicable) - Key Objectives of Topic
-
2-3 Paragraph Abstract, Summarizing the Topic
(Max 300 words)
General Information
Abstract submitters may submit up to two entries for consideration.
All presentations must be free of commercial intent. Incomplete proposals will not be considered.
Call for Abstracts/Case Studies
Dear Colleague,
We would like to warmly invite you to submit a paper or poster abstract for presentation at the PDA BioManufacturing Conference 2025 which will take place on 23-24 September 2025 in Rotterdam, The Netherlands.
Abstracts must be non-commercial in nature, describing new and innovative developments or work that significantly contributes to the body of knowledge of BioManufacturing and all related aspects as stated below. We are particularly interested in case studies.
The Scientific Program Planning Committee will review all proposals carefully and consider podium and poster contributions. We look forward to receiving your topic proposal!
Sincerely,
The Co-Chairs

Sabine Hauck PhD

Maria Papathanasiou PhD
Types of Submissions
Podium
- Approx. 20-minute oral presentation, to be made part of a larger session; please note that you may be considered for the Speed Session, a 10-minute presentation
- One presenter per podium talk. Additional on-site presenters and on-site poster presenters are required to pay appropriate conference registration fees.
Poster
Accepted posters will:
- Be displayed in the exhibit hall and might be a part of the guided poster walk
Get the Attention you deserve!
Maximize your visibility by contributing a podium or poster presentation at PDA BioManufacturing Conference 2025. Leverage this unique opportunity to highlight your work at the event. Posters will be available online post-event.
Topics we are looking for:
- 1. Aseptic Manufacturing
- Single-Use Systems
- Aseptic Processing and Aseptic Process Validation
- Container Closure Integrity Testing
- Cleaning and Disinfection
- Contamination Control Strategy
- Environmental Monitoring
- Biosafety and High-Potent Ingredients (HPAPI)
- Manufacturing Efficiency and Reliability
- Innovation in Fill & Finish
- Developments in Isolator Technology
- Aseptic Process Equipment
- Process Automation
- Implementation of EU GMP Annex 1: 2022 in Practice
- 2. Supply Chain, Manufacturing Logistics, and Facilities
- Shortages of Consumables, Critical Raw Materials, Reagents, Sterilization Equipment, etc.
- Validation Strategies
- Aging Facilities and Retrofit Strategies
- Multimodal Facility Design
- Strategies for Substitutions
- Multi-Sourcing Strategies
- Increasing Manufacturing and Distribution Capacity
- CDMO Selection and Management
- Technology Transfer
- Cost of Goods Reduction
- Capacity Planning
- Increasing Capabilities by Partnerships
- 3. Development and Lifecycle Strategies
- Data Integrity in Development
- Patient-Centric Development
- Preparedness for Future Health Emergencies
- Quality by Design and Advanced Control Strategies
- Drug Product Specifications
- Use of Prior Knowledge for Manufacturing and Quality Control
- Platform Approaches
- Accelerated Development
- Continuous Manufacturing, Process Intensification, and Continuous Process Verification
- Comparability Strategies
- Technology Transfer
- Innovation in Drug Delivery Technologies
- Trends – New/Updated Guidelines/Pharmacopeia and Implementation (e.g., Q6B, Q5A, Q12, Q13, Q2(R2)/Q14, USP665, USP1665)
- Potency Strategy Including Modeling and Statistics
- Point of Care Manufacturing/Personalized Approaches/Decentralized Manufacturing
- 4. Product Approaches
- “Bio Betters” and Biosimilars
- Precision Vaccinology, Prophylactic/Therapeutic Vaccines
- High-Concentration Biopharmaceuticals for Administration
- Antibodies and Related Products
- Live Biotherapeutics
- Antibiotics and Phage-Based Products
- Enzymes and Enzyme Replacement Therapy
- Orphan Drugs
- Antibody-Drug Conjugates
- mRNA Products, Inactivated Viral mRNA Vaccines
- Viral and Non-Viral Vectors
- Nano Capsules
- Oligonucleotides/Synthetic Peptides
- Highly Potent/Toxic Substances
- Checkpoint Inhibitor Therapy
- Cell Therapy
- Gene Therapy (Including Genome Editing Products)
- Targeted Radionuclide Therapy
- 5. Upstream and Downstream Processing
- Scale-Up/Scale-Down Models
- Cell Banking Including Cryopreservation and Freeze-Drying
- Cell Culture
- New and Modified Culture Media
- High-Yield Processes
- Novel Production Formats
- Virus Clearance
- Concentration and Purification Technology
- Freezing-Thawing Technologies for Large Volumes
- 6. Formulation and Filling
- Formulation Technology
- Visual Inspection
- (Sub-)Visible Particle Characterization
- Process Control
- Serialization and Traceability
- New Developments for Filling Lines
- RABS/Isolator Technology
- Material Transfer from Filling to Lyophilization in Aseptic Environment
- Blow-Fill-Seal
- In-Use Administration Studies and CSTD (Closed System Transfer Devices)
- Formulation Development
- Novel Delivery Systems
- Stability and Stability Trending
- Novel Excipients
- Surfactants
- 7. Lyophilization
- Primary Containers (Syringes, Polymer Material, and Nested Rack Systems)
- Lyophilization Process (Equipment, Development, and Optimization)
- Advanced Equipment/Innovative Technology
- Loading/Unloading Systems
- Controlled Nucleation Techniques
- Alternative/Natural Refrigerants to React to Greenhouse Gases Regulation
- Continuous Lyophilization and Alternative Technologies (e.g., Spray Freeze-Drying, Foam Drying, Spin/Shell Freezing)
- Solid State Analytical Techniques
- New Modalities Including Viruses, Virus-Like Particles, and Lipid Nanoparticles
- PAT Tools and Process Monitoring
- EU GMP Annex 1 and Lyophilization
- Containment Strategies for High-Potency Active Pharmaceutical Ingredients (HPAPI)
- Emerging Excipients
- 8. New Technologies and Innovations
- Digital Applications in Real-Life Biomanufacturing
- Industry 4.0
- Innovations in Equipment
- Robotics and Automation
- Artificial Intelligence Including Large Language Models and Machine Learning
- Data Management and Data Analytics
- Modeling and Simulations, Process and Predictive Stability Modeling
- Augmented and Virtual Reality
- Digital Twins
- Real-Time Process Control/Feedback
- Modular Facilities and Multi-Purpose Facilities
- 3D Printing
- Genome Editing/CRISPR-CAS 9
- Simulation Tools (e.g. Computational Fluid Dynamics)
- 9. Quality Control
- Analytical Development, Validation, and Lifecycle
- High-Throughput Testing
- Advanced/Rapid Micro Methods
- Sterility Testing
- Contamination Testing (Endotoxin, RNAse, Particulate, Adventitious Agents, etc.)
- Extractables and Leachables
- Biological Assays
- In-Vivo vs. In-Vitro Strategies (Including Organ-On-a-Chip, 3R Initiative, Horseshoe Crab Replacement, etc.)
- National Control Laboratories Testing
- Acceleration of Product Release and Access
- Process Analytical Technology
- Stability, Predictive Stability Profiles
- Impact of ICH Q14
- 10. Sustainability
- Reduction of Energy and Resource Consumption
- Environmental Protection, Controls, and Standards
- Optimized Cycle Times
- Per- and Polyfluoroalkyl Substances (PFAS) Ban
- Application of AI for Sustainability
- Waste Management, Recycling, and Circular Economy
- Net Zero Initiative
- Suppliers and Manufacturers Collaboration
- Single-Use Materials
- Alternatives to Plastics e.g. for Delivery Devices
- 11. Manufacturing-Related Regulatory Aspects/Case Studies
- Regulatory Perspective on Biomanufacturing Innovations
- Pharmacopoeias Considerations and Convergence
- Specification Setting
- Global Convergence/Harmonization of Regulatory Guidelines and Reliance
- Application of Reliance/Collaborative Assessment or Novel Regulatory Approaches
- Quality Risk Management
- Data Integrity in the Digital World
- Emerging Markets
- Inspection Trends
- Prevention of Drug Shortages
- Updates to the EU Variation Regulation
- Post-Approval Changes in a Global Perspective
Poster Information
All posters will be printed by PDA and displayed as part of the exhibition.
Please send your final printable PDF file and poster title to [email protected].
Important
Poster presenters are required to pay a full conference registration fee.
Join our guided poster walk in our exhibition hall and gain more visibility. You will have the chance to engage with our audience!
Poster Display Dimensions
Please find the PDF dimension requirements below:
Exhibition and Sponsorship Opportunities
PDA is seeking vendors who provide products/services in support of this conference. Space on-site is limited and is on a first-come, first-serve basis.
Exhibition: 23-24 September 2025
To reserve your space, please contact Christopher Haertig at [email protected].